Novel Target Identification and Drug Repositioning for COVID-19 based on Interaction Network, Molecular Design and Machine Learning | Pandemic PACT Tracker

Key facts

Disease
COVID-19
Funder
SERB India
Principal Investigator
Dr. Deva Priyakumar
Research Location
India
Lead Research Institution
International Institute of Information Technology
Research Priority Alignment
N/A

Research Category
Therapeutics research, development and implementation
Research Subcategory
Pre-clinical studies
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable

Abstract

Computational identification and validation of COVID-19 molecular targets

Publicationslinked via Europe PMC

Last Updated:2 days ago

View all publications at Europe PMC

COVID-19 Risk Stratification and Mortality Prediction in Hospitalized Indian Patients: Harnessing clinical data for public health benefits.

Authors
Alle S, Kanakan A, Siddiqui S, Garg A, Karthikeyan A, Mehta P, Mishra N, Chattopadhyay P, Devi P, Waghdhare S, Tyagi A, Tarai B, Hazarik PP, Das P, Budhiraja S, Nangia V, Dewan A, Sethuraman R, Subramanian C, Srivastava M, Chakravarthi A, Jacob J, Namagiri M, Konala V, Dash D, Sethi T, Jha S, Agrawal A, Pandey R, Vinod PK, Priyakumar UD.
Publish Year
2022
Journal
PloS one
DOI
10.1371/journal.pone.0264785

View at Europe PMC

MoleGuLAR: Molecule Generation Using Reinforcement Learning with Alternating Rewards.

MEMES: Machine learning framework for Enhanced MolEcular Screening.